Immune / Lymphatic Systems

October 2014 Vol. 9 No. 10

Author: Marie-Elena Barry, DNP, RN

Health care professionals are at high risk for exposure to vaccine-preventable diseases and infections. Safeguard yourself, your patients, and your family members. Make sure you and your patients are up to date with recommended vaccines.
What is the difference between a vaccine and an immunization?
A vaccine is an . . .

July 2014 Vol. 9 No. 7

Author: Rose O. Sherman, EdD, RN, NEA-BC, FAAN

On July 16, the U.S. Food and Drug Administration (FDA) approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.
Read more . . .

June 2014 Vol. 9 No. 6

Author: Cindy Lefton, PhD, RN

On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help determine the extent that squamous cell carcinoma has spread in the body’s head and neck region. Lymphoseek can now be used . . .

March 2014 Vol. 9 No. 3

Author: Cathy Catrambone, PhD, RN, FAAN; and Rachel Start, MSN, RN

On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more . . .

November 2013 Vol. 8 No. 11

Author: Amy Garcia, MSN, RN, and Kate Nell, MA, RN

Researchers have developed a new intravaginal ring for the sustained 90-day co-delivery of tenofovir and levonorgestrel, an anti-human immunodeficiency virus (HIV) drug and a contraceptive. Tenofovir is the only topical prophylactic shown to be effective at reducing the sexual transmission of HIV when formulated in a gel . . .

Author: Deborah L. Krueger, MSN, RN, NE-BC, CNRN, CHTP

Infection Control and Epidemiology has published “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.” Access a summary of the recommendations . . .

July 2013 Vol. 8 No. 7

Author: Rose O. Sherman, EdD, RN, NEA-BC, FAAN

Poor sleep quality and quantity during pregnancy can disrupt normal immune processes and may lead to lower birth weights and other complications, according to a study in Psychosomatic Medicine. The results of “Disturbed Sleep and Inflammatory Cytokines in Depressed and Nondepressed Pregnant Women: An Exploratory Analysis of Pregnancy Outcomes” indicate . . .

February 2013 Vol. 8 No. 2

Author: Shelly Chandler, MSN, RN, ACNS-BC; Rita Driver, MSN, RN, ACNS-BC;

You can help patients suffering from this chronic skin disease.

January 2013 Vol. 8 No. 1

Author: BrandeeWornhoff, MSN, RN, CNS-BC; and Paula Spoonmore, MSN, RN, CNS-BC

On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy; it is the first FDA-approved therapy for the indication. Derived from the red sap of the Croton lechleri plant, Fulyzaq is the . . .

November 2012 Vol.7 No. 11

Author: Christina L. Dobson, MSN, RN, FNP-C

On Nov. 6, the U.S. Food and Drug Administration (FDA) approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant of, methotrexate. Read more . . .

September 2012 Vol. 7 No. 9

Author: Kathlyn J. Schumacher, MSN, CRNP, ANP-BC, and Elizabeth A. Leonard, BSN, RN-BC, CCRP

On Sept. 12, the U.S. Food and Drug Administration (FDA) approved Aubagio (teriflunomide), a once-a-day tablet for the treatment of adults with relapsing forms of multiple sclerosis (MS). Read more . . .

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing